Bigger WuXi Biologics block nets $1.5bn
WuXi Biologics Holdings has raised HK$11.5bn ($1.49bn) after increasing a sale of shares in subsidiary WuXi Biologics (Cayman).
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: